1-Benzyl-1,2,3,4-tetrahydro-β-carboline as channel blocker of N-methyl-D-aspartate receptors.
about
Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design.
P2860
1-Benzyl-1,2,3,4-tetrahydro-β-carboline as channel blocker of N-methyl-D-aspartate receptors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
1-Benzyl-1,2,3,4-tetrahydro-β- ...... -methyl-D-aspartate receptors.
@en
1-Benzyl-1,2,3,4-tetrahydro-β- ...... -methyl-D-aspartate receptors.
@nl
type
label
1-Benzyl-1,2,3,4-tetrahydro-β- ...... -methyl-D-aspartate receptors.
@en
1-Benzyl-1,2,3,4-tetrahydro-β- ...... -methyl-D-aspartate receptors.
@nl
prefLabel
1-Benzyl-1,2,3,4-tetrahydro-β- ...... -methyl-D-aspartate receptors.
@en
1-Benzyl-1,2,3,4-tetrahydro-β- ...... -methyl-D-aspartate receptors.
@nl
P2093
P2860
P1476
1-Benzyl-1,2,3,4-tetrahydro-β- ...... N-methyl-D-aspartate receptors
@en
P2093
Friedemann Gaube
Marlene Espinoza-Moraga
Thomas Winckler
P2860
P304
P356
10.1111/J.1747-0285.2012.01317.X
P577
2012-02-01T00:00:00Z